Analysts rate K2M shares: 5 facts

Seven firms gave K2M shares a consensus recommendation of “buy,” according to web breaking news.

Advertisement

Here are five facts:

 

1. The shares have an average one-year price target of $25.50.

 

2. K2M Director Carlos A. Ferrer purchased 38,924 company shares for a total value of nearly $500,015.

 

3. Dr. Ferrer currently owns 39,383 K2M shares.

 

4. On April 26, K2M shares opened at $16.75.

 

5. The market cap is $690.57 million.

 

More device news:
Wenzel Spine’s VariLift-LX on full US commercial launch: 5 key notes
4th patient in INSPIRE study experiences AIS grade improvement: 5 things to know
Life Spine to host physician workshop for new solutions launching in 2016 — 3 highlights

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.